LIVE: While initial cues showed a higher open for India, a global tech and AI-related selloff in stocks the previous day and ...

Stories of women falling victim to domestic abuse, whether physical or emotional, particularly at the hands of their husbands ...

Domestic investors will be reacting to Q3 results from several companies, including Tata Steel, Bajaj Housing Finance, Coal ...

Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...

The fallout for Venture Global Inc., in the wake of a troubled initial public offering, accelerated amid a market selloff ...

Bill Stern, a partner in Goodwin Procter’s financial services practice, said the “pendulum” of regulation is due to swing ...

Learn about Karman Holdings' upcoming $100 million US IPO, their focus on missile and space systems, and the financial ...

HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial ...

The GLP-1 IPO arena has been heating up for the past two years and Metsera’s ask is one the largest in recent history.

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Even so the deal solidifies Venture Global’s place in the public markets with an impressive $50 billion market cap. And it ...